Literature DB >> 19231794

Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates.

Jonathan M Grasko1, Richard P Herrmann, Samuel D Vasikaran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19231794     DOI： 10.1016/j.joms.2008.11.005

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN： 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  7 in total

1.  Osteonecrosis and atypical fractures-common origins?

Authors:  G Subramanian; J C Fritton; S Y P Quek
Journal:  Osteoporos Int       Date:  2012-03-10       Impact factor: 4.507

Review 2.  The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future.

Authors:  Samantha Pozzi; Noopur Raje
Journal:  Oncologist       Date:  2011-04-14

3.  Association of low-energy femoral fractures with prolonged bisphosphonate use: a case--control study.

Authors:  S D Vasikaran
Journal:  Osteoporos Int       Date:  2009-05-13       Impact factor: 4.507

Review 4.  American Society of Biomechanics Journal of Biomechanics Award 2013: cortical bone tissue mechanical quality and biological mechanisms possibly underlying atypical fractures.

Authors:  Joseph R Geissler; Devendra Bajaj; J Christopher Fritton
Journal:  J Biomech       Date:  2015-02-02       Impact factor: 2.712

5.  Bilateral atypical femoral fractures in a patient with multiple myeloma treated with intravenous bisphosphonate therapy.

Authors:  Ichiro Tonogai; Tomohiro Goto; Daisuke Hamada; Toshiyuki Iwame; Shinji Yoshioka; Takahiko Tsutsui; Yuichiro Goda; Hiroshi Egawa; Koichi Sairyo
Journal:  Case Rep Orthop       Date:  2014-07-22

6.  Prevention Of Skeletal Related Events In Multiple Myeloma: Focus On The RANK-L Pathway In The Treatment Of Multiple Myeloma.

Authors:  Ricardo D Parrondo; Taimur Sher
Journal:  Onco Targets Ther       Date:  2019-10-14       Impact factor: 4.147

7.  Paradoxical Stress Fracture in a Patient With Multiple Myeloma and Bisphosphonate Use.

Authors:  Edwin Chiu; Michael Cabanero; Gurinder Sidhu
Journal:  Cureus       Date:  2020-08-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.